Harold Andrews - Sabra Healthcare CFO, Executive VP, Secretary and Controller
| SBRA Stock | USD 13.99 0.28 1.96% |
CFO
Mr. Harold W. Andrews, Jr. is the Executive Vice President, Chief Financial Officer and Secretary of the Company. He served as Sabras Treasurer and Secretary from May 2010 to November 2010 and has served as Sabras Executive Vice President, Chief Financial Officer and Secretary since November 2010. From 1997 to 2017, Mr. Andrews was a member of, and a member of the management committee of, Journey Health Properties, LLC and Journey Lane 5, LLC, two real estate holding entities he organized to own and lease specialized healthcare facilities and a commercial office building. From 1997 to May 2008, Mr. Andrews was also a member, a member of the management committee and Chief Financial Officer of CareMeridian. Previously, from 1996 to 1997, Mr. Andrews served as the Vice President of Finance for Regency Health Services, Inc., a provider of postacute care services. Prior to that time, he spent 10 years in public accounting at Arthur Andersen LLP, including serving as senior manager for publicly traded healthcare and real estate companies since 2010.
| Age | 60 |
| Tenure | 14 years |
| Professional Marks | CPA |
| Address | 1781 Flight Way, Tustin, CA, United States, 92782-0539 |
| Phone | 888 393 8248 |
| Web | https://www.sabrahealth.com |
Sabra Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0259 % which means that it generated a profit of $0.0259 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0172 %, meaning that it created $0.0172 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0. At present, Sabra Healthcare's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 59.5 M, whereas Total Assets are forecasted to decline to about 4.2 B.Management Performance
| Return On Equity | 0.0172 | ||||
| Return On Asset | 0.0259 |
Sabra Healthcare REIT Leadership Team
Elected by the shareholders, the Sabra Healthcare's board of directors comprises two types of representatives: Sabra Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabra. The board's role is to monitor Sabra Healthcare's management team and ensure that shareholders' interests are well served. Sabra Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabra Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Nyland, Executive Management | ||
| Talya NevoHacohen, Executive Vice President Chief Investment Officer, Treasurer | ||
| Michael Costa, CFO VP | ||
| Eliza Gozar, Senior Investments | ||
| Darrin Smith, Executive Investments | ||
| Jessica Flores, Chief VP | ||
| Harold Andrews, CFO, Executive VP, Secretary and Controller | ||
| Lukas CFA, Senior Finance | ||
| Richard Matros, Chairman, CEO and Pres |
Sabra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabra Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0172 | ||||
| Return On Asset | 0.0259 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 5.63 B | ||||
| Shares Outstanding | 231.5 M | ||||
| Shares Owned By Insiders | 1.14 % | ||||
| Shares Owned By Institutions | 96.33 % | ||||
| Number Of Shares Shorted | 9.72 M | ||||
| Price To Earning | 67.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Sabra Stock
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.286 | Dividend Share 1.2 | Earnings Share 0.21 | Revenue Per Share 2.812 | Quarterly Revenue Growth 0.035 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.